Press Releases
Published: June 09, 2021

Desert Oasis Healthcare, Propeller Health expand partnership to improve outcomes for asthma and COPD patients

Patients will use Propeller’s digital health tools to manage symptoms and increase adherence, in partnership with Desert Oasis’ team of clinical pharmacists

June 8, 2021 – Propeller Health today announced an expanded partnership with Palm Springs, Calif. based Desert Oasis Healthcare (DOHC) to increase inhaler adherence, decrease rescue use, and lower healthcare costs for people with asthma and COPD.

The partnership with DOHC expands the use of Propeller’s digital health solution among high-risk COPD patients, who experience avoidable hospitalizations and ER visits at a greater rate than the general population and who can benefit from digital health intervention to manage their symptoms. Through this collaboration, Propeller will be available to over 700 people with asthma and COPD, the majority of them high-risk COPD patients.

DOHC first partnered with Propeller in 2017 on a pilot program for its COPD population. The pilot program enrolled 100 patients and saw marked increases in medication adherence, decreases in rescue events and decreases in healthcare visits for patients on the Propeller program.

Based on the success of the pilot, DOHC expanded the program to serve its full asthma and COPD population in late 2020.

“Propeller has changed the way we provide care to people with asthma and COPD by giving us an objective, collaborative way to monitor patient progress and adjust treatment plans accordingly,” said Thomas Brazeal, PharmD, clinical pharmacist manager of Technology & Outcomes at ‎Desert Oasis Healthcare. “We have observed huge improvements not just in clinical outcomes like adherence and rescue use, but in patient engagement and quality of life.”

The DOHC partnership is also unique in its use of clinical pharmacists to manage patient enrollment, monitoring and outreach, resulting in high patient engagement rates and positive clinical outcomes.

“Our partnership with Desert Oasis Healthcare is a great example of the power of digital health to empower patients and keep them out of the hospital,” said Susa Monacelli, general manager of Propeller Health. “Our goal is to give these patients the tools they need to take their medication on time, avoid preventable symptoms, and ultimately get back to the activities they enjoy.”

In previous clinical studies unrelated to this collaboration, the Propeller platform increased asthma control by 63 percent,1 increased medication adherence by 58 percent,2 and reduced asthma-related emergency department visits and hospitalizations by 57 percent.3

1 Merchant RK et al. J Allergy Clin Immunol Pract 2016
2 Van Sickle D et al. Eur Respir J 2016
3 Merchant RK et al. World Allergy Org J 2018

For media
Desert Oasis Healthcare
Barry Dayton
+1 760.320.8814, ext. 1504

Propeller Health
Rachel Fields
+1 630.901.8265

You Might Also Like

Propeller Health Named a Winner of Fierce Healthcare Innovation Awards 2022

Propeller Health’s precision digital health platform wins the Clinical Information Management category of the Fierce Healthcare Innovation Awards 2022. The platform enables physicians and care teams to proactively identify at-risk patients in between routine visits and provide more timely clinical interventions.

MADISON, WI, November 15, 2022 – Propeller Health, a leader in precision digital health, today announces its platform for chronic condition management is a Fierce Healthcare Innovation Awards 2022 winner. The program showcases outstanding innovation that is driving improvements and transforming the industry. The Propeller Digital Health Platform for Chronic Condition Management (The Propeller Platform”) enables proactive clinical care by collecting objective patient data and displaying resulting insights directly within a provider’s native workflow. 

At Propeller, data itself is only the beginning – activating it is what powers patient care,” said Susa Monacelli, Propeller Health General Manager. By surfacing the data within clinicians' existing workflow through EHR integrations, we enable their treatment decisions and help identify at-risk patients. Patient self-management coupled with proactive clinician intervention helps improve clinical outcomes and, in turn, economic value for health systems, payers, and patients. Our focus is to do this across connected medications and therapies to change healthcare at scale.”

Propeller Health accelerates push towards value-based care with new digital health solutions for patients, providers and health systems

Announces integrations with multiple leading Electronic Health Record (EHR) systems, introduces a new solution to enable Remote Therapeutic Monitoring (RTM) by healthcare providers, and launches digital platform updates to enable respiratory care at home, in-clinic, and on-the-go.

MIAMI, March 7, 2022 – Propeller Health, a leader in digital health for asthma and chronic obstructive pulmonary disease (COPD), today announced three exciting updates and new solutions to bring its clinically proven, FDA-cleared platform to more patients, providers and health systems.

Integrations expand the reach of Propeller’s digital platform to more health systems
Propeller Health research shows digital health programs help improve outcomes for vulnerable and underserved populations with chronic respiratory conditions
News Announcement at HLTH 2021, Boston MA, October 18, 2021 MADISON, Wisconsin, October 18, 2021 - Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), revealed two recent studies that showed that digital health interventions alongside appropriate care resources and tools can expand access and improve outcomes for elderly and underserved populations. Propeller’s digital health platform includes Bluetooth® connected inhaler sensors that chime medication reminders and record inhaler medication use, paired with a smartphone app that provides education and feedback to support self-management. In a study1 conducted in partnership with Desert Oasis Healthcare, Propeller evaluated the effect of digital health intervention on healthcare resource utilization and medication use in patients with COPD. 56 patients with COPD, average age 75, were enrolled by their clinical pharmacists, who received alerts through Propeller’s clinician portal whenever patients showed low controller medication adherence or high rescue inhaler use.